Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
33 /100
MEDIUM RISK
Score updated Oct 13, 2026

TBPH — Theravance Biopharma, Inc. Dilution Risk Tracker

Track TBPH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TBPH — Get alerts when the score changes →

As of October 13, 2026, Theravance Biopharma, Inc. (TBPH) has a DilutionWatch DilutionScore of 33/100, rated MEDIUM dilution risk. Theravance Biopharma, Inc. has a market capitalization of $884.18M, 51.92M shares outstanding, 174 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰Cash Runway—
📊 Float Risk
55
⚠️ Warrant Exposure
40
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 20%
🔁 Convertible Conversion model 40%
• Significant convertible debt: 26% potential dilution
• Elevated convertible risk (60/100)
🔔 Track TBPH — Get forecast alerts →

Market Data

Market Cap$884.18M
Shares Outstanding51.92M
Float23.70M
Cash$219.77M
Debt$40.50M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore33/100DilutionWatch score record
Shares Outstanding51.92MVerified float table or market cache
Public Float23.70MVerified float table or market cache
Market Cap$884.18MMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 9.1% shares (2026Q1 vs prior)
174 institutional holders · 55.11M shares
#1 Madison Avenue Partners, LP 9.51M shares
#2 Weiss Asset Management LP 7.46M shares
#3 Newtyn Management, LLC 4.84M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.69M
Days to Cover4.5
% of Float7.1%
FINRA data as of Sep 15, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2022-08-08
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TBPH Dilution Snapshot

Theravance Biopharma, Inc. (TBPH) has a DilutionScore of 33/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TBPH's DilutionScore is currently 33/100 (Medium risk), with 4 score changes tracked over 89 days. The score deteriorated from 34/100 (Medium risk).

Period Score Risk Level Duration
Sep 16 – Oct 13, 202633/100MEDIUM28 days
Aug 22 – Sep 15, 202634/100MEDIUM25 days
Aug 14 – Aug 21, 202629/100MEDIUM7 days
Jul 17 – Aug 13, 202634/100MEDIUM28 days
Jul 16, 202635/100MEDIUM1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TBPH shares outstanding have increased 1.7% from 50.67M (Mar 2026) to 51.55M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 24, 202651.55M23.70M▼ 1.45%
May 18, 202651.55M24.04M▼ 2.20%
May 12, 202651.55M24.59M▲ 0.08%
May 10, 202651.55M24.57M▲ 0.58%
May 08, 202651.51M24.42M▼ 0.42%
May 04, 202651.51M24.53M▲ 1.65%
Apr 07, 202651.49M24.13M▼ 0.69%
Mar 27, 202651.49M24.30M▲ 0.94%
Mar 26, 202651.07M24.07M▲ 0.83%
Mar 23, 202650.67M23.87M▲ 0.90%
Mar 21, 202650.67M23.66M▲ 0.91%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TBPH Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TBPH files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TBPH — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TBPH
TBPH FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.